Double maintains 2 strategies that include EYPT - EyePoint Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OCUL | 55.09% | $1.18B | -26.70% | 0.00% |
BEAM | 44.26% | $2.28B | -34.56% | 0.00% |
NTLA | 41.87% | $900.60M | -68.54% | 0.00% |
LAC | 41.66% | $646.40M | -53.82% | 0.00% |
PRCT | 40.92% | $3.17B | +18.59% | 0.00% |
NNOX | 39.19% | $346.91M | -42.09% | 0.00% |
DNLI | 38.95% | $2.12B | -30.43% | 0.00% |
RXRX | 38.76% | $2.60B | -39.15% | 0.00% |
ABCL | 38.71% | $709.21M | -49.47% | 0.00% |
RCKT | 38.56% | $887.16M | -69.97% | 0.00% |
ALEC | 37.66% | $128.81M | -79.13% | 0.00% |
AVXL | 36.77% | $844.69M | +94.32% | 0.00% |
SXI | 36.43% | $2.01B | -7.72% | 0.74% |
KN | 36.36% | $1.41B | +3.47% | 0.00% |
CRSP | 36.28% | $3.53B | -44.74% | 0.00% |
RGNX | 35.50% | $418.72M | -62.84% | 0.00% |
MTH | 35.41% | $5.13B | -14.06% | 3.87% |
RVMD | 35.37% | $7.16B | +18.69% | 0.00% |
IGMS | 35.34% | $71.73M | -88.27% | 0.00% |
CRBU | 35.21% | $93.00M | -80.95% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CAH | -0.02% | $32.15B | +18.26% | 1.51% |
TPB | 0.03% | $1.03B | +97.57% | 0.49% |
ABBV | 0.07% | $374.18B | +19.41% | 2.97% |
CRESY | 0.11% | $664.95M | +25.74% | 9.02% |
SIGI | 0.20% | $5.42B | -14.41% | 1.64% |
ETR | 0.23% | $36.43B | +63.76% | 4.84% |
AMSF | 0.26% | $981.28M | +7.61% | 2.91% |
SEMR | -0.27% | $1.49B | -15.79% | 0.00% |
RPRX | 0.27% | $14.52B | +10.09% | 2.56% |
DTE | -0.28% | $28.42B | +25.46% | 3.08% |
POR | -0.29% | $4.85B | +8.44% | 4.48% |
VTR | 0.31% | $29.60B | +54.20% | 2.66% |
LMT | -0.37% | $109.86B | +5.32% | 2.76% |
GHI | -0.37% | $298.68M | -22.95% | 11.51% |
INVH | 0.40% | $20.86B | -3.02% | 3.32% |
NFG | 0.42% | $7.15B | +50.38% | 2.59% |
DXCM | 0.42% | $29.35B | -43.70% | 0.00% |
G | 0.47% | $8.69B | +51.33% | 1.28% |
PPC | -0.47% | $12.31B | +53.19% | 0.00% |
DIS | 0.50% | $178.72B | -15.29% | 0.97% |
Finnhub
WATERTOWN, Mass., March 17, 2025 -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal...
Yahoo
Some of the losses seen by insiders who purchased US$184.5k worth of EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT...
Yahoo
Q4 2024 EyePoint Pharmaceuticals Inc Earnings Call
Yahoo
Despite a challenging quarter, EyePoint Pharmaceuticals Inc (EYPT) progresses with promising clinical trials and a strong cash position.
SeekingAlpha
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Conference Call March 5, 2025 8:30 AM ETCompany ParticipantsGeorge Elston - EVP and CFOJay...
Yahoo
Although the revenue and EPS for EyePoint Pharmaceuticals (EYPT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -29.84% | $392.24M | 1.43% |
VIXY | -17.69% | $195.31M | 0.85% |
TAIL | -17.14% | $83.83M | 0.59% |
WEAT | -13.89% | $122.51M | 0.28% |
YEAR | -12.97% | $1.28B | 0.25% |
UNG | -11.41% | $456.14M | 1.06% |
TPMN | -10.35% | $33.27M | 0.65% |
ULST | -9.42% | $584.04M | 0.2% |
USDU | -9.41% | $214.47M | 0.5% |
UUP | -7.42% | $332.64M | 0.77% |
DBE | -6.44% | $54.72M | 0.77% |
CORN | -5.82% | $54.28M | 0.2% |
BCI | -5.68% | $1.35B | 0.26% |
IYK | -5.55% | $1.43B | 0.4% |
TFLO | -5.05% | $6.79B | 0.15% |
UGA | -4.82% | $85.26M | 0.97% |
FTGC | -4.61% | $2.51B | 1.02% |
DBC | -4.53% | $1.33B | 0.87% |
GSG | -4.47% | $1.03B | 0.75% |
BUXX | -4.43% | $229.45M | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 58.55% | $48.98M | 0.69% |
XPH | 45.65% | $158.65M | 0.35% |
XBI | 45.37% | $5.66B | 0.35% |
GNOM | 45.36% | $57.10M | 0.5% |
RSPA | 44.12% | $280.76M | 0% |
IWC | 43.75% | $845.76M | 0.6% |
ARKG | 43.14% | $1.07B | 0.75% |
PBE | 42.07% | $240.72M | 0.58% |
PTH | 40.61% | $115.04M | 0.6% |
IWO | 40.54% | $11.19B | 0.24% |
IBB | 40.40% | $6.06B | 0.45% |
IWM | 39.05% | $65.55B | 0.19% |
VTWO | 38.96% | $11.13B | 0.07% |
IZRL | 37.59% | $98.51M | 0.49% |
SCHA | 37.29% | $16.35B | 0.04% |
KAPR | 37.24% | $186.31M | 0.79% |
KJAN | 37.14% | $322.85M | 0.79% |
PRNT | 36.94% | $82.54M | 0.66% |
GSSC | 36.70% | $520.64M | 0.2% |
CALF | 36.43% | $5.41B | 0.59% |
Current Value
$6.001 Year Return
Current Value
$6.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -23.69% | $22.97B | +19.12% | 1.11% |
ED | -14.85% | $38.30B | +22.37% | 3.09% |
T | -14.56% | $192.30B | +56.12% | 4.14% |
PGR | -14.15% | $160.98B | +33.59% | 1.79% |
ACGL | -14.14% | $34.70B | +7.20% | 0.00% |
TRVG | -13.95% | $107.67M | +82.95% | 0.00% |
ALL | -13.04% | $55.70B | +29.60% | 1.80% |
PEP | -11.88% | $201.82B | -14.67% | 3.69% |
AEP | -11.03% | $56.63B | +27.81% | 3.41% |
FE | -10.26% | $22.96B | +4.02% | 4.29% |
VZ | -10.17% | $184.17B | +7.92% | 6.13% |
LRN | -9.75% | $5.35B | +93.84% | 0.00% |
PG | -9.62% | $392.88B | +3.52% | 2.40% |
WTW | -9.03% | $33.35B | +21.86% | 1.05% |
CLX | -8.81% | $17.90B | -1.57% | 3.34% |
CME | -8.53% | $96.05B | +23.35% | 3.94% |
AON | -8.46% | $84.93B | +20.41% | 0.69% |
KMB | -8.46% | $46.13B | +11.43% | 3.53% |
POST | -8.39% | $6.32B | +5.96% | 0.00% |
PM | -8.24% | $237.07B | +65.37% | 4.37% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BOND | 0.02% | $5.47B | 0.7% |
LTPZ | 0.06% | $723.35M | 0.2% |
SPTS | 0.09% | $5.96B | 0.03% |
FXY | -0.16% | $528.73M | 0.4% |
PWZ | -0.17% | $712.47M | 0.28% |
IBDQ | 0.18% | $3.19B | 0.1% |
TLT | -0.29% | $51.55B | 0.15% |
SPSK | 0.30% | $293.42M | 0.5% |
SPTL | -0.33% | $11.67B | 0.03% |
IBTF | 0.34% | $2.24B | 0.07% |
CCOR | 0.37% | $63.91M | 1.18% |
CLOI | -0.40% | $997.25M | 0.4% |
USTB | -0.40% | $1.11B | 0.35% |
XLP | -0.42% | $16.37B | 0.09% |
IBMO | -0.42% | $505.91M | 0.18% |
SCHQ | -0.47% | $910.73M | 0.03% |
VGLT | -0.47% | $9.91B | 0.03% |
BCD | -0.52% | $244.58M | 0.3% |
ICLO | -0.64% | $355.46M | 0.2% |
SHV | 0.65% | $19.68B | 0.15% |